Financials
- Market Capitalization 26.46 M
- Employee 16
- Founded 2013
- CEO N/A
- Website www.lanternpharma.com
- Headquarter Texas, United States
- FIGI BBG00GM6LK17
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-1.93
市销率
-390.6
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 4476 | BYSI BeyondSpring, Inc. - Ordinary Shares | 0.67 USD | +4.69% | -4.29% | -40.71% | -60.82% | 27.55 M USD | ||
| 4480 | NNVC NanoViricides, Inc. Common Stock | 1.24 USD | -3.88% | -5.34% | -20.00% | +22.76% | 26.84 M USD | ||
| 4491 | ATOS Atossa Therapeutics, Inc. - Common Stock | 2.58 USD | -2.27% | +0.78% | +12.66% | +239.47% | 25.75 M USD | ||
| 4501 | EVAX Evaxion A/S - American Depositary Share | 3.01 USD | -4.44% | -9.34% | +7.50% | -9.34% | 25.10 M USD |